ADSCs supplemented with HGF therapy were able to significantly mitigate CCl4-induced liver fibrosis in diabetic mice by inhibiting the α-SMA and collagen-I expression, results that highlight the key role of HGF in liver recovery after injury. The gene discussed is ACTA1; the disease is Hepatic fibrosis.